Cohort plc

LSE:CHRTIndustrialsLSE
View on Yahoo Finance
£10.86496.46MMarket Cap
Current Market PriceUpdated 55 minutes ago

William O'Neil

gemini2 months ago@ £13.54
BUY

"Cohort plc exhibits many hallmarks of a classic CAN SLIM growth stock. It has posted excellent current and annual earnings growth (C, A) and is a technical and fundamental leader in a top-performing industry group (L, M). The company is bolstered by new products and a strategic acquisition (N), and benefits from powerful geopolitical tailwinds. The primary concerns are the high valuation (trailing P/E of ~31) and recent significant insider selling (S). However, the ~25% pullback from its 52-week high, potentially driven by these sales, may offer an attractive entry point as the stock forms a new price base. Given the record order book providing long-term visibility and the overwhelming fundamental momentum, the stock rates as a 'BUY' for investors with a tolerance for growth stock volatility."

-19.8%Since Report
£13.54 £10.86Price Change
9/28/2025
Report Date

Overview

This report provides a comprehensive investment analysis of Cohort plc (LSE:CHRT), a UK-based technology group specializing in the defence and security markets. The analysis is conducted in the style of expert investor William J. O'Neil, utilizing his CAN SLIM methodology to assess the stock's potential for significant capital appreciation.

Financial and Business Overview

Cohort plc operates as a parent company to seven agile businesses across the UK, Australia, Germany, and Portugal, organized into two segments: Communications & Intelligence and Sensors & Effectors. The company serves a global client base in defence and related markets. For the fiscal year ending April 30, 2025, Cohort reported record financial results, demonstrating powerful momentum. Revenue surged by 33% to £270 million, and pre-tax profit increased by 29% to £25.6 million. Basic Earnings Per Share (EPS) grew by a solid 19% to 45.07p. The company's financial health is robust, underpinned by a record-breaking closing order book of £616.4 million, which provides excellent revenue visibility into the mid-2030s. The company has also demonstrated a commitment to shareholder returns, increasing its dividend by 10% to 16.30p per share, continuing an unbroken streak of dividend growth since its 2006 IPO.

Market Position & Competitive Advantages

Cohort operates as a strategic mid-tier supplier in the burgeoning global defence industry. Its competitive advantage lies in its diversified portfolio of specialized, high-technology subsidiaries. These businesses offer niche, advanced solutions (e.g., submarine sonar, electronic warfare, satellite communications) that are critical components for larger prime contractors and government agencies. This agile structure allows Cohort to innovate and deliver advanced solutions with speed, a key advantage in the rapidly evolving security landscape. The primary tailwind is the significant increase in global defence spending, driven by geopolitical tensions and NATO commitments. However, risks include the cyclical nature of government defence budgets and intense competition from larger, more established players like QinetiQ and Chemring. Furthermore, a recent Moody's report on UK credit strategy warns that smaller and mid-cap industrial firms face pressures from higher leverage and tighter financing conditions, which could pose a structural risk to companies in Cohort's size category. The company's future growth is also tied to its ability to continue making successful, value-accretive acquisitions like the recent purchase of EM Solutions.

Stock Performance

Cohort's stock has been a strong performer, with a 52-week change of +42.5%. Over the past three months, it has gained approximately 33.9%, demonstrating powerful momentum leading up to its recent earnings report. The stock is trading above its 200-day moving average, a bullish technical indicator. However, it is currently trading at 1354p, which is approximately 25% below its 52-week high of 1796p. This pullback occurred shortly after the release of excellent annual results and may be attributed to a combination of profit-taking and news of insider share sales, potentially creating a new base and an attractive entry point for investors.

CAN SLIM Analysis

Current Quarterly Earnings Per Share (EPS) Growth:

C - EXCELLENT: Cohort has demonstrated outstanding recent earnings acceleration. For the full fiscal year 2025 (reported July 16, 2025), the company announced a 19% increase in basic EPS to 45.07p. Underlying this, pre-tax profit grew by an impressive 29% and adjusted operating profit rose 30%. This powerful earnings growth comfortably exceeds the 18-20% minimum threshold preferred by the CAN SLIM strategy.

Annual Earnings Increases:

A - STRONG: The company has a multi-year track record of growth. The most recent annual EPS growth was 19% for FY2025. Furthermore, the vesting of executive long-term incentives was based on achieving a total Compound Annual Growth Rate (CAGR) of 19.09% over the past three years, confirming a history of strong, sustained performance. While analyst forecasts for the next three years predict a more moderate average annual growth of 8.6%, the recent outperformance and positive management outlook suggest estimates may be revised upwards. This strong historical and recent performance satisfies the 'A' criterion.

New Products, Management, or Price Highs:

N - POSITIVE (New Products & Catalysts): Cohort is actively innovating. The company is set to showcase a range of new and next-generation technologies at the DSEI UK defence exhibition, including its KraitSense anti-submarine warfare (ASW) solution, the Ancilia decoy launcher, and SeaEagle digital fire control systems. The recent acquisition of EM Solutions, a specialist in maritime satellite communications, also acts as a significant new catalyst for growth. The one weakness in the 'N' category is the stock price, which is currently about 25% off its 52-week high, meaning it is not breaking out from a price perspective.

Supply and Demand:

S - CAUTION: As a smaller company with a market cap of ~£617 million and ~45.6 million shares outstanding, the supply is relatively limited, which can lead to rapid price appreciation on strong demand. However, there has been significant insider selling. On the day of its record results, three top directors sold a combined £9.76 million in shares. While they still retain a substantial 3.7% stake, a sale of this magnitude is a bearish signal. More recent director sales were disclosed as being for the purpose of covering tax liabilities on vested share awards, which is a neutral event. The overall picture on supply is mixed; the selling pressure has created a potential buying opportunity, but the large discretionary sale is a point of concern that requires monitoring.

Leader or Laggard:

L - LEADER: Cohort is a leader within its specific high-tech defence niches. While not a large-cap industry giant, it is considered a 'strategic supplier' by analysts, serving critical roles for major defence programs. The stock's performance has significantly outpaced the broader UK market over the past year (+42.5% vs. +5.4%), identifying it as a clear market leader. Its record order book and position in a leading industry group (Aerospace & Defense) further confirm its leadership status.

Institutional Sponsorship:

I - LIKELY POSITIVE: While specific data on the quality of institutional ownership is not provided, there are strong positive indicators. The stock is covered by at least three analysts, and the company recently conducted a successful £41 million share placing to help fund an acquisition, which points to solid institutional support. Being listed on the AIM market may mean a slightly lower institutional following than a main market company, but its growth and track record suggest it is on the radar of professional investors.

Market Direction:

M - POSITIVE: The stock is benefiting from a powerful tailwind. The Aerospace & Defense sector is in a confirmed uptrend due to a 'new era of defence' characterized by rising geopolitical tensions and increased government spending commitments from NATO members, including the UK. This strong industry group movement provides a favorable market environment for Cohort and its peers, fulfilling the 'M' criterion.

Conclusion

Cohort plc exhibits many hallmarks of a classic CAN SLIM growth stock. It has posted excellent current and annual earnings growth (C, A) and is a technical and fundamental leader in a top-performing industry group (L, M). The company is bolstered by new products and a strategic acquisition (N), and benefits from powerful geopolitical tailwinds. The primary concerns are the high valuation (trailing P/E of ~31) and recent significant insider selling (S). However, the ~25% pullback from its 52-week high, potentially driven by these sales, may offer an attractive entry point as the stock forms a new price base. Given the record order book providing long-term visibility and the overwhelming fundamental momentum, the stock rates as a 'BUY' for investors with a tolerance for growth stock volatility.

Research Sources (22 found)

Cohort plc Reports Record Financial Results and Positive ...

Published: 9/24/2025

Cohort (AIM:CHRT) - Stock Analysis

Published: 9/28/2025

Cohort PLC, CHRT:LSE forecasts - FT.com - Markets data

Published: 7/16/2025

CHYM 2025 Q2 Financial Analysis | AIME by AInvest

Published: 6/30/2025

Coherus Oncology | Coherus Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update

Published: 8/7/2025

The Competitor Analysis Template that Actually Convinces ...

Published: 4/9/2025

Hims And Hers Health Inc Market share relative to its competitors, as of Q4 2024

Published: 6/23/2025

Blink Charging Co Market share relative to its competitors, as of Q1 2025

Published: 6/23/2025

Archer Aviation (ACHR) Competitors Analysis

Published: 5/19/2025

Cohort Plc Share Price (CHRT)

Published: 7/16/2025

Cohort’s shares rally after soaring defence demand spikes profit

Published: 7/16/2025

Cohort exhibiting at DSEI UK 2025

Published: 8/14/2025

Director/PDMR Shareholding | Company Announcement

Published: 9/10/2025

Cohort (CHRT) RNS Announcements

Published: 4/16/2025

Directors are selling this UK growth stock. So why should ...

Published: 7/31/2025

How to Use Cohort Retention Analysis to Improve ...

Published: 9/18/2025

What is Cohort Analysis? Strategies to Boost Retention

Published: 6/25/2025

a large and longitudinal machine learning cohort study - PMC

Published: 9/28/2025

Even under mounting tariff pressures, the consumer is ...

Published: 9/21/2025

The State of American Debt 2025: 36% Debt Growth ...

Published: 5/29/2025

Mind the (Credit Risk) Gap

Published: 8/26/2025

The Curious Case of Young Families' Shrinking Mortgages

Published: 7/29/2025

Search Queries Generated

CHRT Cohort financial health profitability analysis

CHRT Cohort market share competition analysis

CHRT Cohort recent news acquisitions partnerships

CHRT Cohort competitive advantages risks analysis

CHRT Cohort debt levels financial pressures

Company

Symbol:CHRT.L
Exchange:London
Sector:Industrials
Industry:Aerospace & Defense

Financial Metrics

P/E Ratio (TTM):24.68
Forward P/E:0.22
P/B Ratio:311.35
Book Value:3.49

Earnings Data

0.44
EPS (TTM)
48.27
Forward EPS
0.60
Current Year EPS
0.16
Dividend Rate
Next Earnings:
4 months ago

Trading Volume

0.16M
Avg Daily Volume (3M)
0.17M
Avg Daily Volume (10D)

52-Week Range

Low
963.30
+0.13%
High
1796.00
-0.40%
Current Position
963.301086.001796.00

Moving Averages

50-Day Average:1261.12
-0.14%
200-Day Average:1344.97
-0.19%

Dividend Data

Dividend Rate:0.1600
Dividend Yield:151.00%
Trailing Annual Dividend Yield:0.02%

Share Data

45.71M
Shares Outstanding
Created: 9/28/2025Data Fetched: 2 months agoPrice Updated: 55 minutes ago